Chronic Thalidomide and Chemoembolization for Hepatocellular Carcinoma

BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used to curtail tumor vasculature and delay tumor progression in hepatocellular carcinoma (HCC). We conducted a phase I trial to evaluate the efficacy and toxicity of thalidomide when combined with TACE in patients with advanced HC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Wu, Jennifer, Ng, Jennifer, Christos, Paul J., Goldenberg, Alec S., Sparano, Joseph, Sung, Max W., Hochster, Howard S., Muggia, Franco M.
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2014
Témata:
Clinical Trial Results
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257750/
https://ncbi.nlm.nih.gov/pubmed/25361625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0283
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky